chrisvoncsefalvay/vaers-outcomes huggingface dataset:
very achy right leg just below hip on right side of leg; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.    On 26-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jun-2021, the patient experienced PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg). At the time of the report, PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No relevant concomitant medications were reported. No treatment information was provided.
Patient presented to ED with SOB. Of note, had recent kyphoplasty. Patient reports fever, productive cough, and sore throat as well as fatigue. Patient found to have post-operative pneumonia and was treated with antibiotics. Per the EUA, hospitalizations are to be reported irrespective of attribution to the vaccine
exhausted, fatigued; threw up; cold chills; vomiting; sweaty; diarrhea; nauseous; dizzy; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPERHIDROSIS (sweaty), DIZZINESS (dizzy), DIARRHOEA (diarrhea), NAUSEA (nauseous) and CHILLS (cold chills) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Attention deficit hyperactivity disorder. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for ADHD, BUPROPION HYDROCHLORIDE (WELLBUTRIN) and ATENOLOL for an unknown indication.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced DIZZINESS (dizzy) and NAUSEA (nauseous). On 28-Aug-2021, the patient experienced HYPERHIDROSIS (sweaty), DIARRHOEA (diarrhea), CHILLS (cold chills) and VOMITING (vomiting). On 29-Aug-2021, the patient experienced VOMITING (threw up). On an unknown date, the patient experienced FATIGUE (exhausted, fatigued). At the time of the report, HYPERHIDROSIS (sweaty), DIZZINESS (dizzy), DIARRHOEA (diarrhea), NAUSEA (nauseous), CHILLS (cold chills), VOMITING (threw up), FATIGUE (exhausted, fatigued) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2021, Blood pressure measurement: high (High) 172/108.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Anti diarrheal medication  Patient crapped her pants
Per chart docmumention:18 yo (17 at onset) AA E2 with S/S left shoulder pain/weakness suspect HNPP with onset approximately 8 days after Vaccine receipt on  6 June hep B (lot #SKB 539T3), IIV (CSL U55306), TDaP (SKB AH4LF), MCV4 (PMC U510AA), and ADENOVIRUS (BRR 34600234A). Per notes neurology 18 JUL the symptoms came on gradually over the course of 24h with the worst of them being on the second day after onset. Since then, they improved slightly initially (when he got 6-day course of steroids) but then worsened again. He is very limited by this. Had a nerve conduction study which showed globally abnormal nerve conduction throughout. He denies any preceding viral illness. R provider signs/symptoms were most consistent with a left brachial plexopathy, primarily involving axillary and suprascapular nerve conduction study, have high suspicion for HNNP, with peripheral palsy potentially being cause by continuous wearing of over-the-shoulder camel back. Also on the differential is an inflammatory polyneuropathy, potentially triggered by immunizations, exposure to new pathogens, or increase physical activity. Patient initially declined HNPP genetic testing, but subsequent testing demonstrated positive gene deletion PMP22 consistent with HNPP.
It has been 25 days since I took the AZ vaccine. Below are the side effects and significant  blood test results:  Day25: INR 1.29, CRP 4.8 Day 20 INR 1.05  In addition, I have been having an ongoing  37.3 fever since day 15 which  goes back to normal 36.5 at night. Moreover i have been having light bruising on the arms and fee  without any physical impact. my blood vessels / veins on hands, arms and legs  are inflamed and cleary visible. i have been also having  a feeling of tiredness and fatigue. Please advise on what I should do.   Regards
Patient has a small capillary hemangioma in hair line at nape of neck just R of midline. 1 day after her vaccine family noted hair loss overlying this hemangioma. They were seen by myself on 11/2 and she did have a smooth area of hair loss overlying her hemangioma with ongoing hair loss noted circumferentially around this area consistent with alopecia areata. She has been referred to dermatology for additional evaluation
I contracted COVID-19 on 08/03/2022 with symptoms of chest tightness, cough, and congestion. I took NYQUIL for my symptoms at night, and I was prescribed molnupiravir on 08/04/2022. I was ill for 5 days before my symptoms began to resolve. I am experiencing lingering congestion, but all other symptoms resolved.
The contact is concerned she received the incorrect dose of vaccine.; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (The contact is concerned she received the incorrect dose of vaccine.) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939906, 001B21A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Metastatic breast cancer. Concomitant products included ANASTROZOLE, FULVESTRANT and DENOSUMAB for Metastatic breast cancer.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced INCORRECT DOSE ADMINISTERED (The contact is concerned she received the incorrect dose of vaccine.). On 27-Oct-2021, INCORRECT DOSE ADMINISTERED (The contact is concerned she received the incorrect dose of vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She has not experienced any known symptoms. The contact has discussed the dosage with her infectious disease person who pointed out her medications are not immunosuppressive but are more hormonal.  Concomitant medication use was unknown Treatment information was unknown
Pt developed severe pain on left where vaccine was administrated. Hard to move shoulder and lost sleep over pain. Took Vicodin to alleviate pain. Saw PCP who did an MRI that showed the vaccine was administered to high, hitting the tendon and causing tendonitis and bursitis. Pain improving at this point.
Headache, Body aches, swollen eyes/face, dry scratchy feeling when breathing, low grade fever I called staff with pharmacy COVID Vaccination team and notified her of the adverse reaction. The employee was seen at the medical clinic by "staff", Dr, nurse practitioner. Employee was informed that these were all common side effects + she should go ahead and take the second vaccine when it's scheduled on 1/26/21
PAIN IN THE LEFT ARM ALL THE WAY TO HAND, NUMBNESS ON FINGERS ALSO.
Severe brain fog within the hour of taking vaccine, GI motility stopped, hormones began fluctuating wildly - periods twice per month for months, reactions to foods and meds began, temperature dysregulation started, sleeping issues, nausea and headaches, meds that helped my conditions no longer work, dysautonomia affecting my nervous system where things that are usually regulated without thinking are no longer functioning correctly.
Tingling in Arms, Chest Pain, Mouth, Gum & Teeth Pain, Swollen Lymph Nodes, Swollen and raised lump at injection site, Hot and cold Sweats, Dizziness, loss of balance
Client received a Moderna booster instead of a Pfizer Boooster.  Received the booster dose of 0.25mL.
I have had a huge reddened arm (entire) from forearm/wrist up to shoulder approx 2 1/2 months, severe throbbing pain, severe muscle pain and weakness.
This is not serious spontaneous case from a nurse in the USA involving Red Face. The reporter causality is not related to FluMist. A nurse reported a red face, runny nose, ear infection, and nasal congestion in female patient 1 day after receiving her FluMist vaccine. This 5 year old girl with a history of allergies presented in the reporters office on Nov 08 2004 with an ear infection. The patient received an intramuscular injection of ceftriaxone sodium for treatment of the ear infection and she received the FluMist vaccine. On Nov 23 200, the patient had a runny nose and nasal congestion. On Nov 15 2004, the infant presented in the reporters office with an ear infection. The patients runny nose had improved but her face was red from nose to her lip. The reporter stated she did not know if the patients face was red due to rubbing her face or if it was red due to the blowing of her nose. No further information is available.
Redness to thigh quarter sz. 8/13/09.  Warm compresses.  8/14/09 site not as red per mom.
Information has been received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, current condition and concomitant medication were not provided. On 29-NOV-2018, the patient received an expired dose of VAQTA 25/0.5 (lot # N023953 with expiration date 05-NOV-2018) intramuscularly for prophylaxis(expired product administered). No adverse effects were reported in the patient.
To ED 2 weeks after covid vaccine. He told provider he had developed sharp and stabbing anterior chest pain and was diagnosed with pericarditis and had been on anti-inflammatories for about a week. Now is having palpitations with increasing frequency over the past week.
no adverse effect reported; the patient was administered an expired dose of vaqta; This spontaneous report as received from a nurse refers to a patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies, historical drugs, familial history and concomitant medications were not reported.   On 09-SEP-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA) Expiration date: 05-SEP-2019 (strength, route of administration, lot/batch # were not reported) for prophylaxis (expired product administered). The patient experienced no adverse event. No product quality complaint was reported.
On about 4/18/2022, I developed a dry cough. The dry cough continued through the end of the week. On 4/22/2022, I saw my doctor for a routine visit. I mentioned the dry cough to her, but she didn't seem concerned. The cough neither improved nor worsened that weekend or on Monday, 4/25/2022. I asked my doctors if I should get another dose of COVID-19 vaccine, and they told me I should, so I got one that afternoon. I went to work on 4/26/2022, and I was told that half our employees were out sick with COVID-19. I was thus instructed to test myself for COVID-19 at the worksite, and I got a positive result when I did. I was then instructed to go home and self-isolate. I never developed any symptoms besides dry cough and a bit of fatigue. I was eventually prescribed the medication another person was given, though I don't remember the name of it. The medication helped, and the cough diminished in severity. I was finally over the cough maybe around mid-May 2022. If I remember correctly, I don't think I was out of work for over a week.
Fever of 100.7, body aches, Weakness, Lightheaded, fatigue, and headache
Extreme headache (so  intense that it caused pain to cough or sneeze, even lightly) Fever (100 degrees F) Chills / sweat  Treatment: Advil/Ibuprofen
10/29/21 presents to ED with flu like symptoms for 4 days, loss of taste and smell, nausea, vomiting, diarrhea, decreased appetite, cough, fever, chills and generalized weakness. PMH HTN, CAD S/P PCI with stent placement, hyperlipidemia, urothelial carcinoma S/P renal stents, obstructive sleep apnea and ESRD on PD.
No further AE; Temperature: 70F; This spontaneous report was received from a pharmacist and a nurse, referred to a 4-year-old patient of unknown gender. Information about the patient's pertinent medical history, concomitant medications, and drug reactions/allergies was not provided.  On 02-MAR-2023, doses of varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot# W025273, expiration date: 10-AUG-2024) experienced a temperature excursion of 70 Fahrenheit (F) for 9 minutes with no previous temperature excursion. It was not known if digital data logger was involved. On 07-JUN-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5ml/once, lot #W025273, expiration date: 10-AUG-2024, administered for prophylaxis (strength, anatomical location, and route of administration were not provided) (Product storage error). No symptoms were reported. No further adverse event (AE) details and no product quality complaints (PQCs) were reported.  This case is one of multiple reports from the same reporter.
Apparently contracted GBS from a HIGH DOSE flu vaccine which caused some severe nerve pain, affecting tendons (finger, ankle, heel), daily that changes locations such as shoulders, neck (constant stiff neck) wrists, knee areas; tingling in arms; and then overnight on 10/27/13 got up with a significant loss of hearing (at least a 30% loss).
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored (at the temperature of 34-35- unit unknown) unspecified doses of MMR II lot # K011317, expiry date: 13-AUG-2016, therapy type: rHA or lot# K014833, expiry date: 14-SEP-2016, therapy type: rHA (dose, site and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
Pt reported area of numbness/decreased sensation lateral to left eye  approx 15 minutes after vaccine administration. Improved after approx 15 minutes. No other symptoms. Narrative:
ACHINESS; FEVER; CHILLS; This spontaneous report received from a patient concerned a 42 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021;10:15 am on left arm for prophylactic vaccination. No concomitant medications were reported.  On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F, 101.5 F. On 13-MAR-2021, the subject experienced achiness. On 13-MAR-2021, the subject experienced fever. On 13-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and achiness, and the outcome of chills was not reported. This report was non-serious.
36 year old patient, two minutes after getting her third dose of Gardasil 9, reports feeling dizzy, as she's leaving she holds herself immediately to avoid falling. Patient is oriented. Vitals are taken Glucose 132, Sat 99% and pulse 88.
I had the vaccine in my left arm about 11:30 a.m. and started to feel a cramp behind my left knee that afternoon. I took Motrin that evening and again the next day but stopped after Thursday and the pain worsened. I is like a charley horse that will not go away. It is now the following Tuesday and I still have much pain walking and now feel lower back pain as well.
This case was reported by a healthcare professional and described the occurrence of seizure in a 4-month-old male subject who was vaccinated with ROTARIX lyophilized formulation (GlaxoSmithKline), PENTACEL (non-gsk). Concurrent medical conditions included gastroesophageal reflux disease, spitting up described as "expelling formula" and vomiting. Concurrent vaccination included pneumococcal vaccines (non-gsk); Wyeth Labs; unknown; unknown given on 8 September 2012. The healthcare professional reported that 4 month old subject received routine pediatric vaccines at age 2 and 4 months of age. No adverse events were reported after the first vaccine. On 06 July 2012, the subject started ZANTAC at 22.5 mg (oral) twice daily for gastroesophageal reflux disease. On 8 September 2012 at 09:30 the subject received 2nd dose of ROTARIX lyophilized formulation (1 ml, oral) and on 8 September 2012 the subject received 2nd dose of PENTACEL (details unknown). On 9 September 2012, 24 hours after vaccination with PENTACEL and ROTARIX lyophilized formulation and 65 days after starting ZANTAC, the subject experienced seizure described as, repetitive head turning, refusal to eat, arm rigidity and stared blankly into space. The subject was seen at 4 months for routine vaccination and developed seizures 24 hours after the vaccinations. He was still on ZANTAC at this time as well. The subject was reported to "turn his head to the right repeatedly" (repetitive head turning) and refused to eat. While being changed his right arm became rigid and he "developed a blank stare" (stared blankly into space). The episode lasted for about 20-30 seconds and was repeated a total of four times that morning. The subject was hospitalized for 2 days and there was no evidence of reason for seizures. He was afebrile, WNL [within normal limits] EEG [Electroencephalogram], CT scan [Computerized tomogram], and labwork. Seizures were considered to be secondary to immunization with DTaP vaccine from another manufacturer, PENTACEL. The subject was hospitalised and the healthcare professional considered the events were life threatening. At the time of reporting the events were resolved. The healthcare professional considered the events were unrelated to vaccination with ROTARIX lyophilized formulation and ZANTAC. The healthcare professional considered the events were related to the vaccination with PENTACEL due to the DTaP component of the vaccine.
Information regarding Hib titer vaccine (haemophilus B conjugate vaccine (diphtheria crm 197 protein conjugate) injection) was received form an attorney, regarding a male patient who developed mercury poisoning, neurological injuries, neurodevelopment injuries, developmental delays, learning disabilities, social delays and social deficit, impairment of fine motor skills, gastrointestinal illness and immune system dysfunction. The patient received a dose on 7/1/1997. The patient also received a dose of Diphtheria Tetanus toxoids acellular pertussis vaccine (Acel Imune) on 7/1/1997. Relevant history was not provided. Indication for Hib Titer vaccine was immunisation. Product was administered on an unspecified date. Dose regimen was not provided. Additional suspect medication included Diphtheria/Tetanus toxoids/acellular pertussis vaccine (Acel Imune), Diphtheria/ Tetanus toxoids/Pertussis vaccine absorbed/Haemophilus B conjugate (Tetramune), Engerix B (hepatitis B vaccine) and Hyprho D (immunoglobulin human anti RH), which was given to the mother of the patient during her pregnancy. Concomitant medications were not reported. On an unspecified date, the patient developed mercury poisoning (metal poisoning), neurological injuries (nervous system disorder), neurodevelopment injuries (nerve root injury), developmental delays, learning disabilities, social delays, social behavior (disturbance in social behavior), impairment of fine motor skills (psychomotor skills impaired), gastrointestinal illness (gastrointestinal disorder) and immune system dysfunction (immune system disorder). These events reportedly resulted in persistent or significant disability or incapacity. No additional information was available at the time of this report.
Information was received from a licensed practical nurse via Pfizer, Inc. (manufacturer report number 2016514979) on 28-NOV-2016 concerning a child (age unknown). No information was provided regarding the child's medical history. The nurse reported that her child was administered PREVNAR followed by PNEUMOVAX23 four weeks later by a hematologist/oncologist (lot number, dosage, and route of administration not provided). No further information was available at this time. Additional information has been requested.
myocarditis; This is a spontaneous report from a non-contactable consumer (patient) reported for another patient (1st case of two children reports). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. He states he would not have taken it. He indicates his brother is a doctor and has conveyed to him it is experimental and per VAERs this is a reported adverse event. Asks how it is being given to kids and he knows two children that have experienced myocarditis. He states is sitting there like a vegetable. States he eats healthy, a vegan and runs. The patient experienced myocarditis on an unspecified date. The outcome of the event was unknown.  The response to consumer question was provided as Approximately 44,000 participants 12 years of age and older were randomized equally and received 2 doses of for up to 24 months, for assessments of safety and efficacy against COVID-19. The Pfizer-BioNTech COVID-19 Vaccine is currently available in the U.S. under an Emergency Use Authorization (EUA) granted by the FDA on 11Dec2020. On 7May2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the FDA for approval of the vaccine to prevent COVID-19 in individuals 16 years of age and older. Data to support the BLA will be submitted by the companies to the FDA on a rolling basis over the coming weeks, with a request for Priority Review. The goal date for a decision by the FDA will be set once the BLA is complete and formally accepted for review by the agency. A submission for the 12 to 15 years group will occur once the required data six months after the second vaccine dose are available.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021823458 as same reporter/drug/AE, different patient
Information has been received from a consumer concerning her 30 month old white son with no known allergies or medical history, who on 01-APR-2006 was vaccinated in the left thigh with a first dose of Varivax (lot # 648310/0278P), there was no illness at the time of vaccination and no bad reaction was noted. On approximately 11-OCT-2006 the patient developed a mild case of chickenpox. Unspecified medical attention was sought. On 15-OCT-2006 the patient recovered. There was no product quality complaint involved. Additional information is not expected.